Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid for Bleeding Gastrointestinal Angioectasias
NCT07125508Phase 3Completed
- Sponsor
- Louisiana State University Health Sciences Center
- Start
- Aug 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in gastrointestinal angiodysplasia (GIAD) comparing Tranexamic Acid with Placebo (2 arms). Primary endpoint: Number of participants with improved hemoglobin concentrations and/or blood transfusions requirement at 3 months. Started Aug 2023; status: completed.
02
Drugs
tranexamic acid
03
Conditions
gastrointestinal angiodysplasia (GIAD)
Beyond the preview
Go deeper on NCT07125508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07125508.